CompletedNot Applicable

Compassionate Mind Training for Teachers (CMT-T)

Brazil40 participantsStarted 2025-10-09

Plain-language summary

Literature has reported the emergence of various mental disorders in teachers at this level, including common mental disorders (CMDs) such as depression and anxiety, leading to increased job turnover and detrimental to the teaching-learning process. To prevent and promote mental health in this professional population, compassion-based interventions have proven effective, especially in situations of distress, by reducing fears of compassion and self-criticism, considered preventive factors for depressive and anxiety disorders. Given the growing evidence of the benefits of compassion for mental health, and the prevalence of common mental disorders in elementary school teachers, aggravated by the new coronavirus pandemic, this project aims to evaluate the effectiveness and feasibility of Compassionate Mind Training for Teachers (CMT-T) on the mental health of elementary school teachers in the public education system in the city of Aracaju.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:a) of both sexes; b) teachers from the state and municipal elementary and secondary schools in the city of Aracaju, Sergipe; c) teachers performing their professional activities in the classroom; d) professionals available to participate in the sessions proposed by the program. \- Exclusion Criteria:serious psychiatric problems (e.g., psychotic disorders, major depression, bipolar disorder, suicidal ideation, borderline personality disorder, and substance abuse) \-

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Viability

Timeframe: From enrollment to the end of treatment in 6 weeks.

Self-criticizing/Attacking and Self-Reassuring Scale

Timeframe: From enrollment to the end of treatment in 18 weeks.

Depression Anxiety and Stress Scale

Timeframe: From enrollment to the end of treatment in 18 weeks.

Burnout Clinical Subtype Questionnaire

Timeframe: From enrollment to the end of treatment in 18 weeks.

Trial details

NCT IDNCT07716657

SponsorUniversidade Federal de Sergipe

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-13

View on ClinicalTrials.gov More Depression Anxiety Disorder trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Viability

Timeframe: From enrollment to the end of treatment in 6 weeks.

Self-criticizing/Attacking and Self-Reassuring Scale

Timeframe: From enrollment to the end of treatment in 18 weeks.

Depression Anxiety and Stress Scale

Timeframe: From enrollment to the end of treatment in 18 weeks.

Burnout Clinical Subtype Questionnaire

Timeframe: From enrollment to the end of treatment in 18 weeks.